Axsome Therapeutics AXSM Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's operating lease ROU assets?
- Axsome Therapeutics (AXSM) reported operating lease ROU assets of $20.01M in Q1 2026.
- How has Axsome Therapeutics's operating lease ROU assets changed year-over-year?
- Axsome Therapeutics's operating lease ROU assets decreased by 14.1% year-over-year, from $23.29M to $20.01M.
- What is the long-term trend for Axsome Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Axsome Therapeutics's operating lease ROU assets has grown at a 64.4% compound annual growth rate (CAGR), from $1.74M to $20.86M.
- What does operating lease ROU assets mean?
- The value of the company's right to use leased property, such as office or lab space.
- How do you interpret operating lease ROU assets?
- Changes reflect the expansion or contraction of the company's physical footprint and long-term lease commitments.
- How does operating lease ROU assets compare across companies?
- Standardized across companies with significant real estate footprints; reflects operational scale.